Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/25/2010WO2010031497A1 New process for the preparation of iloperidone
03/25/2010WO2010031346A1 Freeze-dried preparation of tetrodotoxin and the producing method thereof
03/25/2010WO2010031266A1 The salts of n-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridyl methyl)amino-3-pyridinecarboxamide
03/25/2010WO2010031265A1 Pharmaceutical composition for the treatment of proliferative diseases
03/25/2010WO2010031251A1 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof
03/25/2010WO2010031248A1 Thiazolium salt compound and the use of treating the protein aging disease
03/25/2010WO2010031238A1 Alexipharmic cigarette filter material and their praparation
03/25/2010WO2010031184A1 Azaindole derivatives as crth2 receptor antagonists
03/25/2010WO2010031183A1 Indole derivatives as crth2 receptor antagonists
03/25/2010WO2010031182A1 Indole derivatives as crth2 receptor antagonists
03/25/2010WO2010031096A1 Antimicrobially and antivirally acting composition
03/25/2010WO2010014595A3 Methods and compositions for delivering therapeutic agents in the treatment of b-cell related disorders
03/25/2010WO2010014572A3 Modulation of toll-like receptor 9 expression by antisense oligonucleotides
03/25/2010WO2010013224A3 Curcumin nanoparticles and methods of producing the same
03/25/2010WO2010013110A3 Composition comprising estrone and hydrocortisone for use in the topical treatment of baldness
03/25/2010WO2010013078A3 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
03/25/2010WO2010011375A3 Inhibitors of janus kinases
03/25/2010WO2010011367A3 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
03/25/2010WO2010011117A3 Ndga-containing composition for the suppression of transglutaminase
03/25/2010WO2010011111A3 Composition for control of aging and / or extension of life, containing dapsone as active ingredient
03/25/2010WO2010010346A3 Topical compositions for use during tooth eruption
03/25/2010WO2010009405A9 Targeted nitroxide agents
03/25/2010WO2010008976A3 Combined calcium, magnesium and vitamin d supplements
03/25/2010WO2010008777A3 Fused azabicyclic pyridines
03/25/2010WO2010008735A9 Solid states of o-desmethylvenlaf axine salts
03/25/2010WO2010008733A3 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
03/25/2010WO2010008619A3 Extended release pharmaceutical formulations of s-adenosylmethionine
03/25/2010WO2010008491A3 Lactose compositions with decreased lactose content
03/25/2010WO2010007515A3 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract
03/25/2010WO2010007085A3 Use of gcn5 inhibitors in medicine
03/25/2010WO2010006315A3 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and intiviral, antibacterial, and anticancer agents
03/25/2010WO2010006123A3 19-nor-vitamin d analogs with 1,2-dihydrofuran ring
03/25/2010WO2010006121A3 19-nor-vitamin d analogs with 3,2-dihydrofuran ring
03/25/2010WO2010005807A3 Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats)
03/25/2010WO2010005637A3 Electrostatically charged multi-acting nasal application, product, and method
03/25/2010WO2010004283A3 Sulfonylurea receptor and means for treating ischaemia
03/25/2010WO2010003084A3 Phosphodiesterase 4 inhibitors
03/25/2010WO2009158447A9 Materials and methods for suppressing and/or treating neurofibroma and related tumors
03/25/2010WO2009158387A3 Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
03/25/2010WO2009156853A3 Compounds, compositions, and methods useful for modulating the expression of histone deacetylase (hdac) gene expression and/or activity
03/25/2010WO2009155335A3 Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization
03/25/2010WO2009155056A3 Non-hormonal steroid modulators of nf-kb for treatment of disease
03/25/2010WO2009154741A8 Thiophene or thiazole derivatives and their use as pi3k inhibitors
03/25/2010WO2009153496A3 Ppar agonist compounds and preparation and uses thereof for treating diabetes and/or dyslipidemia
03/25/2010WO2009152228A3 Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen
03/25/2010WO2009151496A3 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
03/25/2010WO2009148623A3 Methods and related compositions for the treatment of cancer
03/25/2010WO2009148287A3 Novel α-iso-cubebene compound extracted from schisandra chinensis and composition containing the compound as active ingredient for preventing and treating inflammatory diseases
03/25/2010WO2009146540A8 N-piperidinyl acetamide derivatives as calcium channel blockers
03/25/2010WO2009146539A8 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
03/25/2010WO2009145814A3 Pyrimidines and pyridines useful as inhibitors of protein kinases
03/25/2010WO2009141533A3 Pyrrole derivatives, preparation of same and therapeutic application thereof as cannabinoid cb1 receptor antagonists
03/25/2010WO2009141090A9 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
03/25/2010WO2009139630A3 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
03/25/2010WO2009138583A3 Use of a composition containing ergosterol or a natural extract of a vegetable or animal microorganism
03/25/2010WO2009137074A9 Compositions and methods for treating diabetic ulcers
03/25/2010WO2009127974A3 Pharmaceutical formulation for treating cardiovascular disease
03/25/2010WO2009122351A3 Anti-parkinsonian compounds mppe
03/25/2010WO2009117677A3 Controlling intracellular calcium levels associated with an ischemic event with o-desulfated heparin
03/25/2010WO2009115252A3 Substituted pyrazolamides and the use thereof
03/25/2010WO2009114540A3 Vitamin d compounds and methods for reducing ocular hypertension (oht)
03/25/2010WO2009111998A3 Specific impurities of montelukast
03/25/2010WO2009111603A3 Deitary supplement for eye health
03/25/2010WO2009106555A3 Sterilized sucralfate gel
03/25/2010WO2009098404A8 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
03/25/2010WO2009090484A3 Mesalazine tablet
03/25/2010WO2009073620A9 Ido inhibitors
03/25/2010WO2009050289A3 Solid dispersion product containing n-aryl urea-based compound
03/25/2010WO2009018010A9 Methods for the treatment or prevention of hemorrhagic conditions
03/25/2010WO2009003199A8 Nasal and ophthalmic delivery of aqueous corticosteroid solutions
03/25/2010WO2008157460A8 Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties
03/25/2010WO2008100848A3 Novel agent for in vivo pet imaging of tumor proliferation
03/25/2010WO2008092091A3 Mao inhibiting n-benzyl-n-propargyl-amines useful for treating obesity
03/25/2010US20100077496 MO-1, A Gene Associated With Morbid Obesity
03/25/2010US20100077493 Genes and pathways involved in bipolar disorder
03/25/2010US20100077492 Oxidative DNA Damage Protection
03/25/2010US20100077491 Modulators of RNF5 and Uses Thereof
03/25/2010US20100076489 Wound closure material
03/25/2010US20100076246 Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of Disease
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076174 ErbB Interface Peptidomimetics And Methods Of Use Thereof
03/25/2010US20100076094 Formulation containing phosphate derivatives of electron transfer agents
03/25/2010US20100076091 Composition and method for suppressing lipooxidation of erythrocyte
03/25/2010US20100076089 Antimicrobial gel formulations
03/25/2010US20100076088 Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
03/25/2010US20100076087 Methods of reduction of interpatient variability
03/25/2010US20100076086 Process for the preparation of o-desmethyl venlafaxine
03/25/2010US20100076085 HCl Polymorphs of 3-((2-(Dimethylamino)methyl-(cyclohex-1-yl))phenol
03/25/2010US20100076084 Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes
03/25/2010US20100076083 Treprostinil administration using a metered dose inhaler
03/25/2010US20100076081 Method for producing salt of 4-sulfinylamino-1-cyclohexanecarboxylic acid
03/25/2010US20100076080 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products
03/25/2010US20100076079 Pharmaceutical Compositions Of Short-Acting Sedative Hypnotic Agent
03/25/2010US20100076077 Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
03/25/2010US20100076076 Novel palladium complexes inhibit n-myristoyltransferase activity in vitro and cancer growth in vivo
03/25/2010US20100076075 Methods of treating neurological disease using antagonists of the nmda receptor complex
03/25/2010US20100076074 Carbamate reducers of skeletal muscle tension
03/25/2010US20100076073 Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
03/25/2010US20100076072 Compositions and methods of vitamin e administration
03/25/2010US20100076071 Use of equol for treating skin diseases
1 ... 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 ... 7860